Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

ODYSSEY Trial Team

Résultat de recherche › examen par les pairs

14 Citations (Scopus)

Empreinte numérique

Plonger dans les sujets de recherche 'Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial'. Ensemble, ils forment une empreinte numérique unique.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology